RETINAL DEPOSITS

This adverse event was reported 203 times

These drugs are most commonly taken by patients reporting RETINAL DEPOSITS:

# Drug Count
0 CERTOLIZUMAB PEGOL 38
1 METHOTREXATE SODIUM 37
2 METHOTREXATE 33
3 RITUXIMAB 29
4 ADALIMUMAB 23
5 HYDROXYCHLOROQUINE SULFATE 17
6 IBUPROFEN 16
7 ETANERCEPT 15
8 IBUPROFEN AND DIPHENHYDRAMINE CITRATE 15
9 TOCILIZUMAB 13
See all common drugs associated with RETINAL DEPOSITS

RETINAL DEPOSITS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VARDENAFIL HYDROCHLORIDE 5 0.0610
1 VORETIGENE NEPARVOVEC-RZYL 2 0.0132
2 LUMASIRAN 1 0.0026
3 VARDENAFIL 1 0.0017
4 GOLD 8 0.0014
5 BROLUCIZUMAB 5 0.0014
6 PEMIGATINIB 1 0.0012
7 ERDAFITINIB 1 0.0008
8 VERTEPORFIN FOR INJECTION 1 0.0007
9 IBUPROFEN AND DIPHENHYDRAMINE CITRATE 15 0.0006
See all drugs enriched for association with RETINAL DEPOSITS